8:50
IMAPAC Opening Remarks
8:55
Chairman Opening Remarks
Opening Plenary: Building Southeast Asia’s Biologics & Vaccine Ecosystem
9:00
Panel Discussion: Building a Resilient Biologics & Vaccine Ecosystem in Southeast Asia: From Capacity to Capability
- Bridging gaps across R&D, manufacturing, and supply chain to create a connected regional ecosystem
- Public-private partnerships: Aligning governments, industry, and academia to accelerate innovation
- Strengthening regional self-sufficiency vs. global dependency in vaccine and biologics production
- Talent, infrastructure, and policy: What’s needed to position Southeast Asia as a global hub
Panelist:
👤 Dr. Mohd Azlan bin Zaharudin, Director, Malaysian Vaccine Project Office (MVPO), Ministry of Science, Technology & Innovation (MOSTI), Malaysia
9:45
Enabling Southeast Asia's Vaccine & Biopharma Ecosystem Through Strategic Partnerships and Innovation
- Supporting vaccine and biologics development through integrated technology, manufacturing, and supply chain solutions
- Accelerating regional growth through public-private partnerships and ecosystem collaboration
- Building resilient and future-ready capabilities to strengthen Southeast Asia's position in the global life sciences industry
👤 Reserved for Solution Providers
10:00
Scaling for Resilience: Strengthening Local Manufacturing & Supply Chain Capabilities
- Investing in local manufacturing capacity vs. reliance on global supply chains
- Technology transfer models and partnerships with global biopharma players
- Workforce development: building a skilled talent pipeline for biologics production
- Ensuring quality, compliance, and regulatory readiness for global markets
👤 Dr. Heba Wali, Vice CEO, VBC Vaccines and Biotechnology City, Egypt
10:25
From Policy to Practice: Strengthening National Immunisation Ecosystems Across Southeast Asia
- Bridging policy and execution: overcoming gaps in last-mile vaccine delivery and coverage
- Strengthening public health infrastructure to support adult and life-course immunisation
- Integrating digital health systems for real-time monitoring, tracking, and decision-making
- Building resilient immunisation programmes in the face of future pandemics and outbreaks
👤 Vinod Kumar Bura, Coordinator IVD Unit, WHO SEARO ,India
10:50
Morning Tea Break, Exhibition Viewing & 1-1 Attendee Networking
Therapeutic Biologics Market Growth & Commercial Opportunities in Southeast Asia
11:30
Expanding Patient Access to Biologics Across Southeast Asia
- Addressing affordability and reimbursement challenges for biologic therapies
- Increasing access to innovative treatments in emerging ASEAN markets
- Balancing healthcare sustainability with growing demand for biologics
11:55
Unlocking Commercial Success in Southeast Asia's Evolving Biologics Market
- Identifying high-growth therapeutic areas and market opportunities
- Leveraging partnerships to accelerate regional market expansion
- Enabling market access through innovative commercialization strategies
👤 Reserved for Solution Providers
12:10
Biosimilars as a Growth Driver for Southeast Asia's Healthcare Systems
- Current adoption trends and physician confidence in biosimilars
- Unlocking cost savings while maintaining quality of care
- Regulatory and market factors influencing biosimilar uptake across ASEAN
12:35
Lunch, Exhibition Viewing & 1-1 Attendees Networking
R&D, Clinical Development & Translational Science for Biologics
1:40
Accelerating the Journey from Discovery to Clinical Development for Biologics
- Advancing biologic candidates from preclinical research to first-in-human studies
- Leveraging innovative discovery platforms to improve development success rates
- Overcoming key challenges in early-stage biologics development
2:05
Enabling Faster and Smarter Biologics Development Through Integrated R&D Solutions
- Enhancing candidate selection and development through advanced technologies
- Streamlining preclinical and clinical workflows to reduce development timelines
- Supporting regulatory readiness with data-driven development strategies
👤 Reserved for Solution Providers
2:20
Bridging Translational Research and Clinical Impact in Biologics Development
- Translating scientific discoveries into clinically meaningful therapies
- Integrating biomarkers and precision medicine into biologics development
- Strengthening academia-industry collaborations to accelerate innovation
2:45
Navigating Clinical Development and Regulatory Pathways for Biologics in Southeast Asia
- Designing efficient clinical development strategies for biologics across ASEAN markets
- Addressing evolving regulatory requirements and approval pathways
- Leveraging regional collaboration to accelerate development and patient access
3:10
Afternoon Tea Break, Exhibition Viewing & 1-1 Attendee Networking
Clinical Adoption, Reimbursement & Market Access for Therapeutic Biologics
3:50
Generating Actionable Evidence: Medical Affairs as the Architect of Value in Biologics Access
👤 Deepak Mukherjee, Country Medical Director, Roche, Indonesia
4:15
Expanding Patient Access to Innovative Biologics Across Southeast Asia
- Addressing barriers to patient access for high-value biologic therapies
- Improving affordability through sustainable funding and reimbursement models
- Ensuring equitable access across diverse healthcare systems in ASEAN
4:40
Leveraging Real-World Evidence to Strengthen Biologics Value and Adoption
- Generating real-world data to support clinical and payer decision-making
- Demonstrating long-term outcomes and value of biologic therapies
- Enhancing collaboration between medical affairs, healthcare providers, and stakeholders
5:05
Chairman Closing Remarks
5:10
End of Conference - Day 1
8:50
IMAPAC Opening Remarks
8:55
Chairman Opening Remarks
Bioprocessing & Manufacturing Innovation in Southeast Asia
9:00
Panel Discussion: Scaling Southeast Asia's Biomanufacturing Capacity: From Regional Demand to Global Competitiveness
- What investments are needed to expand biologics manufacturing capacity across Southeast Asia?
- How can manufacturers balance efficiency, quality, and cost while scaling production?
- What role will digitalization, automation, and workforce development play in building globally competitive biomanufacturing hubs?
9:50
Enabling Next-Generation Biomanufacturing Through Innovative Process & Digital Solutions
- Accelerating process optimization through automation and advanced analytics
- Improving manufacturing flexibility and scalability with modern bioprocessing technologies
- Supporting capacity expansion while maintaining quality and regulatory compliance
👤 Reserved for Solution Providers
10:05
Advancing Bioprocessing Excellence to Strengthen Southeast Asia's Biomanufacturing Capabilities
- Optimizing upstream and downstream processes to improve productivity and product quality
- Overcoming scale-up challenges in commercial biologics manufacturing
- Building manufacturing resilience to meet growing regional demand
10:30
Morning Tea Break, Exhibition Viewing & 1-1 Attendee Networking
CDMO & Technology Transfer Partnerships in Southeast Asia
11:10
Building Successful CDMO Partnerships to Accelerate Biologics Manufacturing Growth in Southeast Asia
- Establishing effective collaboration models between biopharma companies and CDMOs
- Overcoming challenges in technology transfer to ensure speed, quality, and regulatory compliance
- Strengthening regional manufacturing networks to improve supply chain resilience and capacity
11:35
Building End-to-End CDMO Capabilities in Southeast Asia: From Tech Transfer to Commercial Supply
- Scaling from clinical to commercial manufacturing within regional CDMOs
- Infrastructure readiness: single-use systems, modular facilities, digitalization
- Ensuring consistency and comparability across sites
- Case studies of successful end-to-end CDMO partnerships
👤 Lutfhi Zarkasyi, Director of Manufacturing, Kalbio Global Medika, Indonesia
12:00
Accelerating GMP Readiness in SEA: Infrastructure, Quality Systems, and Compliance
- Establishing GMP-compliant facilities aligned with global regulatory standards
- Building QA/QC systems and inspection readiness (FDA, EMA, PIC/S)
- Workforce training and capability development for biologics manufacturing
- Common pitfalls in facility qualification and validation
👤 Rakhmat Budi Yuwono, Quality Director, Etana Technologies, Indonesia
12:25
Lunch, Exhibition Viewing & 1-1 Attendees Networking
Future Modalities: ADCs, Protein Therapeutics & Advanced Biologics
1:30
Unlocking the Clinical Potential of Antibody-Drug Conjugates (ADCs) in Oncology
- Advances in ADC design and targeted drug delivery
- Expanding ADC applications across different cancer types
- Clinical development challenges and opportunities for next-generation ADCs
1:55
Enabling the Development and Manufacturing of Advanced Biologics
- Overcoming development and scale-up challenges for ADCs, bispecifics, and complex biologics
- Leveraging innovative technologies to accelerate process development and commercialization
- Supporting quality, regulatory compliance, and manufacturing readiness for emerging modalities
👤 Reserved for Solution Providers
2:10
Bispecific Antibodies: Transforming the Future of Targeted Therapies
- Emerging clinical applications of bispecific antibodies
- Addressing development and manufacturing complexities
- Opportunities for bispecifics across oncology and immune-mediated diseases
2:35
Advancing Next-Generation Protein Therapeutics for Unmet Medical Needs
- Innovations in protein engineering and therapeutic design
- Improving efficacy, safety, and patient outcomes through novel protein formats
- Future opportunities for protein therapeutics in Southeast Asia
3:00
Afternoon Tea Break, Exhibition Viewing & 1-1 Attendee Networking
Leadership Panel: Can Southeast Asia Become a Global Biomanufacturing Powerhouse?
3:40
Leadership Panel: Can Southeast Asia Become a Global Vaccine & Biomanufacturing Powerhouse?
- What will it take for Southeast Asia to become a leading hub for vaccine and biologics manufacturing?
- How can governments and industry accelerate investments in talent, infrastructure, and advanced manufacturing capabilities?
- What role can regional collaboration play in strengthening supply chain resilience and reducing reliance on imports?
4:20
Strengthening GMP and Quality Systems Across Emerging Manufacturing Sites
- Building robust quality culture and compliance systems
- Digital QA/QC and data integrity practices
- Inspection readiness for US FDA, EMA, and WHO PQ
- Managing deviations and ensuring batch consistency
👤 Vipul Doshi, Chief Quality and Compliance Officer, Zydus Lifesciences, India
4:45
Leadership Panel: Building a Self-Reliant Life Sciences Ecosystem in Southeast Asia: From Innovation to Commercialization
- How can Southeast Asia strengthen its end-to-end ecosystem across R&D, clinical development, manufacturing, and commercialization?
- What partnerships are needed between governments, academia, investors, and industry to accelerate innovation?
- How can the region attract global investment while improving access to vaccines and biologics for local populations?
5:25
Chairman Closing Remarks
5:30
End of Conference
For Speaking Opportunities, Kindly Contact:
Caterin Sanggita
Conference Producer
[email protected] | +65 9460 6701
